Trial Profile
Study of tolvaptan in patients with decompensated liver cirrhosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Aug 2016
Price :
$35
*
At a glance
- Drugs Tolvaptan (Primary)
- Indications Liver cirrhosis
- Focus Therapeutic Use
- 09 Aug 2016 New trial record
- 12 Jul 2016 Results published in the Clinical Drug Investigation